ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PRPH ProPhase Labs Inc

5,42
0,11 (2,07%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ProPhase Labs Inc PRPH NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,11 2,07% 5,42 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,30 5,20 5,50 5,42 5,31
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:00GLOBEPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL..
25.4.202414:00GLOBEProPhase Labs to Present at the Planet MicroCap Showcase:..
16.4.202414:00GLOBEProPhase Labs Unveils Project ZenQ-AI
10.4.202414:00GLOBEProPhase Labs Seeks to Transform Esophageal Cancer Detection..
02.4.202403:00GLOBEProPhase Labs Announces Inducement Grant Under Nasdaq..
15.3.202413:00GLOBEProPhase Labs Announces Financial Results for the Year Ended..
08.3.202414:00GLOBEPROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON..
20.2.202414:00GLOBEProPhase Labs Announces Significant Progress in BE-Smart..
14.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202414:00GLOBEProPhase Labs Announces Preliminary Positive Results for..
30.1.202414:00GLOBEProPhase Labs Ushers in New Genomics Era with Jason Karkus..
23.1.202414:00GLOBEPharmaloz Manufacturing Accelerates Expansion, Improves..
04.1.202414:05EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEProPhase poised to ramp up growth at Pharmaloz and Nebula..
13.11.202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:00EDGAR2Form 8-K - Current report
09.11.202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
02.11.202313:00GLOBEProPhase Labs to Host Third Quarter 2023 Financial Results..
17.10.202314:00GLOBEProPhase Labs Announces Substantial Growth Expectations for..
12.10.202314:25GLOBEDSS Inc. Issues Letter to Shareholders
12.10.202314:00GLOBEProPhase Labs to Present at The ThinkEquity Conference
11.8.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202316:40GLOBEProPhase Labs Announces Updated Conference Call Dial-in..
10.8.202314:00EDGAR2Form 8-K - Current report
10.8.202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
03.8.202314:00GLOBEProPhase Labs Teams up with Certis Oncology to Accelerate..
02.8.202314:00GLOBEProPhase Labs to Host Second Quarter 2023 Financial Results..
29.6.202314:05EDGAR2Form 8-K - Current report
29.6.202314:00GLOBENavidea Biopharmaceuticals Rejects ProPhase Labs Offer To..
22.6.202314:30GLOBEProPhase Labs Inc. Sets the Course for Expansion into the..
07.6.202314:00GLOBEProPhase Labs to Present at the Diamond Equity Research..
01.6.202314:30GLOBEProPhase Labs’ Cancer Therapeutic, Linebacker-1,..
11.5.202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
08.5.202314:30GLOBEProPhase Labs hires Dr. Matthew Halpert to Drive Company’s..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock